Antagonism of the Renin-Angiotensin System Can Counteract Cardiac Angiogenic Vascular Endothelial Growth Factor Gene Therapy and Myocardial Angiogenesis in the Normal Heart | Zendy

Anwar J. Siddiqui | Zendy; Agneta MånssonBroberg | Zendy; Thomas Gustafsson | Zendy; KarlHenrik Grinnemo | Zendy; Göran Dellgren | Zendy; Xiaoyan Hao | Zendy; Heléne Fischer | Zendy; Christer Sylvén | Zendy

Open Access

Antagonism of the Renin-Angiotensin System Can Counteract Cardiac Angiogenic Vascular Endothelial Growth Factor Gene Therapy and Myocardial Angiogenesis in the Normal Heart

Author(s) -

Anwar J. Siddiqui,

Agneta MånssonBroberg,

Thomas Gustafsson,

KarlHenrik Grinnemo,

Göran Dellgren,

Xiaoyan Hao,

Heléne Fischer,

Christer Sylvén

Publication year - 2005

Publication title -

american journal of hypertension

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.009

H-Index - 136

eISSN - 1941-7225

pISSN - 0895-7061

DOI - 10.1016/j.amjhyper.2005.04.023

Subject(s) - medicine , angiogenesis , renin–angiotensin system , vascular endothelial growth factor , cardiology , antagonism , vegf receptors , blood pressure , receptor

The aim of this study was to test the hypothesis that angiotensin converting enzyme inhibition or angiotensin II antagonism can counteract cardiac human vascular endothelial growth factor-A165 (phVEGF-A165) induced angiogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research